Circassia Group PLC banner

Circassia Group PLC
LSE:CIR

Watchlist Manager
Circassia Group PLC Logo
Circassia Group PLC
LSE:CIR
Watchlist
Price: 36.5 GBX 0.83%
Market Cap: £152.7m

Circassia Group PLC
Investor Relations

Circassia Group Plc is a holding company, which engages in the development and commercialization of respiratory products. The company is headquartered in Oxford, Oxfordshire and currently employs 128 full-time employees. The company went IPO on 2014-03-13. The firm operates through two segments: NIOX and COPD. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). The COPD segment relates to the Tudorza and Duaklir Pressair products marketed in the United States, where they are indicated for the maintenance treatment of patients with COPD. Its NIOX FeNO measurement and monitoring products are used by physicians around the world to help improve asthma diagnosis and management. Its FeNO diagnosis and management products helps healthcare to professionals manage their patient's asthma. Its NIOX VERO is a non-invasive, point-of-care system that provides FeNO measurements. The firm provides products and services in around 50 countries.

Show more
Loading
CIR
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Ian Roy Johnson
Exec. Chairman
No Bio Available
Mr. Michael Roy David Roller A.C.A., ACA, BA (Hons)
CFO & Director
No Bio Available
Mr. Jonathan Emms
COO & Exec. Director
No Bio Available
Ms. Nina Kataria
Sr. VP Global HR
No Bio Available
Ms. Sarah Duncan
Company Sec.
No Bio Available

Contacts

Address
OXFORDSHIRE
Oxford
Northbrook House, Robert Robinson Avenue
Contacts
+441865405560.0
www.circassia.com